| Title: |
Cost-Effectiveness of the Dabrafenib Schedule in Combination With Trametinib Compared With Other Targeted Therapies, Immunotherapy, and Dacarbazine for the Treatment of Unresectable or Metastatic Melanoma With BRAFV600 Mutation in Colombia |
| Authors: |
Gil-Rojas, Yaneth; Lasalvia, Pieralessandro; Hernández, Fabián; Castañeda-Cardona, Camilo; Castrillón-Correa, Johanna; Herrera, Daniel; Rosselli, Diego |
| Source: |
Value in Health Regional Issues ; volume 26, page 182-190 ; ISSN 2212-1099 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2021 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.vhri.2021.04.008 |
| Availability: |
http://dx.doi.org/10.1016/j.vhri.2021.04.008; https://api.elsevier.com/content/article/PII:S2212109921000741?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S2212109921000741?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.60EE1ADB |
| Database: |
BASE |